Sick Money

Name: Sick Money
Brand: Allen & Unwin
SKU: 9781838850296
Price: 32.99 NZD
Availability: InStock

Sky-high Prices and Dirty Tricks: Inside the Global Pharmaceutical Industry

By Billy Kenber

0.0 (0 reviews)

4.13

( 160 ratings, 16 reviews)

Summary

Sick Money by investigative journalist Billy Kenber exposes the deep dysfunction within the pharmaceutical industry. From exorbitant price hikes on crucial medications to the neglect of vital cancer drugs, Kenber reveals how a system once designed to promote innovation and patient care has been warped by profit motives. The book offers an incisive diagnosis of the crisis and proposes ways for society to reclaim control over drug development and access.
Read More

Format: Paperback / softback

$32⁹⁹

AVAILABLE WITH SUPPLIER Ships from our Auckland warehouse within 4-6 weeks

Found a better price? Request a price match

Sick Money

$32⁹⁹

Book Hero Magic created this recommendation. While it's new and still learning, it may not be perfect - your feedback is welcome! IS THIS YOUR NEXT READ?

This book is ideal for readers interested in healthcare, pharmaceuticals, investigative journalism, policy reform, and anyone concerned about the ethics and economics of medicine production and access.

An urgent call to build a new model for the pharmaceutical industry, from the multi-award-winning Times journalist.

Description

The pharmaceutical industry is broken. From the American hedge fund manager who hiked the price of an AIDS pill overnight to the children's cancer drugs left intentionally to expire in a Spanish warehouse, the signs of this dysfunction are all around. A system built to drive innovation and patient care has been distorted to boost profits.

Unless we take action, we risk a dramatic decline in the pace of drug development and a future in which medicines go to the highest bidder. In Sick Money, investigative journalist Billy Kenber offers a diagnosis of an industry in crisis and a prescription for how we can fight back.

Sick Money distinguishes itself from many other books by its investigative power and meticulous clarity - The Times

Book Hero Magic summarised reviews for this book. While it's new and still learning, it may not be perfect - your feedback is welcome! HOW HAS THIS BEEN REVIEWED?

'Billy Kenber is one of the most promising young journalists in the land, and he has, unsurprisingly, produced a compelling debut which surprises, entertains and inspires dismay. An essential read' - Sathnam Sanghera

'Kenber does a fantastic job, pulling apart the origins of the drugs industry and machinations of its shameless profiteers with surgical precision . . . a must-read for anyone who wants to understand how the drugs industry really does its business' - Jacques Peretti

'A forensic and very readable account of the reforms needed to make the pharmaceutical industry serve the public good as well as private profit . . . Kenber's ground-breaking investigative reporting has led to legal changes, regulatory interventions, and significant benefits for patients and the NHS' - Andrew Grice

'Distinguishes itself from many other books by its investigative power and meticulous clarity' - The Times

Book Details

INFORMATION

ISBN: 9781838850296

Publisher: Canongate Books

Format: Paperback / softback

Date Published: 07 July 2022

Country: United Kingdom

Imprint: Canongate Books

Edition: Main

Audience: Tertiary education, Professional and scholarly

DIMENSIONS

Spine width: 26.0mm

Width: 129.0mm

Height: 198.0mm

Weight: 287g

Pages: 432

Collections

Billy Kenber Education & Reference Non-Fiction

About the Author

Billy Kenber is an investigative journalist at The Times and has worked at the newspaper since 2010. He has won several accolades including prizes at the UK Press Awards, the British Journalism Awards and two prizes from the Medical Journalists' Association including the 2017 award for Outstanding Contribution to Health or Medical Journalism. In 2013 he won the Laurence Stern Fellowship and worked for the Washington Post for three months. He lives in London.

@billykenber